{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:05:55Z","timestamp":1790769955056,"version":"4.1.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Very-low-density lipoprotein (VLDL) is the only lipoprotein containing apolipoprotein B that is secreted from the liver, where VLDL is assembled from apolipoproteins, cholesterol, and triglycerides. The primary function of VLDL is to transport cholesterol and other lipids to organs and cells for utilization. Apart from its role in normal biologic processes, VLDL is also known to contribute to the development of atherosclerotic cardiovascular disease. Large VLDL particles, which are subclassified according to their size by nuclear magnetic resonance spectrometry, are significantly correlated not only with atherosclerosis, but also with insulin resistance and diabetes incidence. VLDL can also be subclassified according to surface electrical charge by using anion-exchange chromatography. The most electronegative VLDL subclass is highly cytotoxic to endothelial cells and may contribute to coronary heart disease. In addition, electronegative VLDL contributes to the development of atrial remodeling, especially in patients with metabolic syndrome, which is an established risk factor for atrial fibrillation. In this review, we focus on the VLDL subclasses that are associated with apolipoprotein alterations and are involved in cardiometabolic disease. The postprandial enhancement of VLDL\u2019s pathogenicity is a critical medical issue, especially in patients with metabolic syndrome. Therefore, the significance of the postprandial modification of VLDL\u2019s chemical and functional properties is extensively discussed.<\/jats:p>","DOI":"10.3389\/fcvm.2022.993633","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T07:21:19Z","timestamp":1664868079000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Spotlight on very-low-density lipoprotein as a driver of cardiometabolic disorders: Implications for disease progression and mechanistic insights"],"prefix":"10.3389","volume":"9","author":[{"given":"Hsiang-Chun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Akhmedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Huang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3791\/61790","article-title":"Isolation and analysis of plasma lipoproteins by ultracentrifugation.","author":"Niimi","year":"2021","journal-title":"J Vis Exp."},{"key":"B2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.","volume":"22","author":"Chapman","year":"1981","journal-title":"J Lipid Res."},{"key":"B3","article-title":"Emerging evidence of pathological roles of very-low-density lipoprotein (VLDL).","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/ATVBAHA.111.241471","article-title":"Intracellular trafficking and secretion of VLDL.","volume":"32","author":"Tiwari","year":"2012","journal-title":"Arterioscl Thromb Vasc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2697364","article-title":"VLDL induced modulation of nitric oxide signalling and cell redox homeostasis in HUVEC.","volume":"2017","author":"Magnifico","year":"2017","journal-title":"Oxid Med Cell Longev."},{"key":"B7","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/JOE-16-0237","article-title":"Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.","volume":"232","author":"Tsai","year":"2017","journal-title":"J Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1021\/acs.analchem.8b02412","article-title":"Quantitative lipoprotein subclass and low molecular weight metabolite analysis in human serum and plasma by (1)H NMR spectroscopy in a multilaboratory trial.","volume":"90","author":"Jimenez","year":"2018","journal-title":"Anal Chem."},{"key":"B9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2015.07.040","article-title":"Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?","volume":"242","author":"Phillips","year":"2015","journal-title":"Atherosclerosis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1365-2796.2012.02562.x","article-title":"Lipoprotein subclass profiles in individuals with varying degrees of glucose tolerance: a population-based study of 9399 Finnish men.","volume":"272","author":"Wang","year":"2012","journal-title":"J Intern Med."},{"key":"B12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.ATV.8.1.79","article-title":"Presence of a modified low density lipoprotein in humans.","volume":"8","author":"Avogaro","year":"1988","journal-title":"Arteriosclerosis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.ATV.0000071350.78872.C4","article-title":"Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins.","volume":"23","author":"Yang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/01.CIR.0000065220.70220.F7","article-title":"Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.","volume":"107","author":"Chen","year":"2003","journal-title":"Circulation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2337\/dc11-1623","article-title":"Effects of electronegative VLDL on endothelium damage in metabolic syndrome.","volume":"35","author":"Chen","year":"2012","journal-title":"Diabetes Care."},{"key":"B16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0076-6879(96)63004-3","article-title":"Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins.","volume":"263","author":"Alaupovic","year":"1996","journal-title":"Methods Enzymol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and Non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients.","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.atherosclerosis.2014.07.008","article-title":"Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides.","volume":"236","author":"Prenner","year":"2014","journal-title":"Atherosclerosis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2010.02.020","article-title":"Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS).","volume":"211","author":"Ren","year":"2010","journal-title":"Atherosclerosis."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.amjcard.2006.06.032","article-title":"Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.","volume":"98","author":"Liu","year":"2006","journal-title":"Am J Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.4103\/0366-6999.213575","article-title":"Elevated levels of very low-density lipoprotein cholesterol independently associated with in-stent restenosis in diabetic patients after drug-eluting stent implantation.","volume":"130","author":"Qin","year":"2017","journal-title":"Chin Med J."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010078","article-title":"Association between Non-HDL-C\/HDL-C ratio and carotid intima-media thickness in post-menopausal women.","volume":"11","author":"Iannuzzi","year":"2021","journal-title":"J Clin Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1373\/clinchem.2004.046748","article-title":"Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.","volume":"51","author":"Petersen","year":"2005","journal-title":"Clin Chem."},{"key":"B24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cca.2011.04.018","article-title":"Postprandial lipoprotein metabolism: VLDL vs chylomicrons.","volume":"412","author":"Nakajima","year":"2011","journal-title":"Clin Chim Acta."},{"key":"B25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.atherosclerosis.2021.11.003","article-title":"Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: the multi-ethnic study of atherosclerosis.","volume":"339","author":"Zeb","year":"2021","journal-title":"Atherosclerosis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"71i","DOI":"10.1016\/s0002-9149(02)02636-x","article-title":"Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.","volume":"90","author":"Mackey","year":"2002","journal-title":"Am J Cardiol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/db09-1114","article-title":"Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.","volume":"59","author":"Mora","year":"2010","journal-title":"Diabetes."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3362","article-title":"Nuclear magnetic resonance lipoproteins are associated with carotid atherosclerosis in type 1 diabetes and pre-eclampsia.","volume":"37","author":"Amor","year":"2021","journal-title":"Diabetes Metab Res Rev."},{"key":"B29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCRESAHA.108.190116","article-title":"Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.","volume":"104","author":"Lu","year":"2009","journal-title":"Circ Res."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85502-0","article-title":"Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice.","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081193","article-title":"Combined LDL and VLDL electronegativity correlates with coronary heart disease risk in asymptomatic individuals.","volume":"8","author":"Shen","year":"2019","journal-title":"J Clin Med."},{"key":"B32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein.","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000130","article-title":"Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.","volume":"2","author":"Mendivil","year":"2013","journal-title":"J Am Heart Assoc."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235939","article-title":"Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond.","volume":"20","author":"Fuior","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2004.12.049","article-title":"The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.","volume":"45","author":"Hamsten","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/271062","article-title":"The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis.","volume":"2011","author":"Hansen","year":"2011","journal-title":"J Lipids."},{"key":"B37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11745-008-3193-2","article-title":"The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis.","volume":"43","author":"Noto","year":"2008","journal-title":"Lipids."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2021.01.011","article-title":"Human apolipoprotein C1 transgenesis reduces atherogenesis in hypercholesterolemic rabbits.","volume":"320","author":"Gautier","year":"2021","journal-title":"Atherosclerosis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jacc.2016.11.065","article-title":"Very-low-density lipoprotein\u2013associated apolipoproteins predict cardiovascular events and are lowered by inhibition of APOC-III.","volume":"69","author":"Pechlaner","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/ATVBAHA.117.310473","article-title":"APOC3 loss-of-function mutations, remnant cholesterol, low-density lipoprotein cholesterol, and cardiovascular risk: mediation- and meta-analyses of 137 895 individuals.","volume":"38","author":"Wulff","year":"2018","journal-title":"Arterioscl Thromb Vasc Biol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.","volume":"371","author":"Jorgensen","year":"2014","journal-title":"N Engl J Med."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309007","article-title":"Apolipoprotein CIII levels and incident coronary artery disease risk: the EPIC-Norfolk prospective population study.","author":"van Capelleveen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/CIRCRESAHA.111.300367","article-title":"Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans.","volume":"112","author":"Graham","year":"2013","journal-title":"Circ Res."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1166-5","article-title":"Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease.","volume":"18","author":"Dai","year":"2019","journal-title":"Lipids Health Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PAT.0000000000000251","article-title":"Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.","volume":"47","author":"Feng","year":"2015","journal-title":"Pathology."},{"key":"B47","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/brv.12005","article-title":"The role of apolipoprotein A5 in obesity and the metabolic syndrome.","volume":"88","author":"Zheng","year":"2013","journal-title":"Biol Rev Camb Philos Soc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"48051","DOI":"10.1074\/jbc.M306898200","article-title":"Apolipoprotein B100 exit from the endoplasmic reticulum (ER) is COPII-dependent, and its lipidation to very low density lipoprotein occurs post-ER.","volume":"278","author":"Gusarova","year":"2003","journal-title":"J Biol Chem."},{"key":"B49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes."},{"key":"B50","doi-asserted-by":"publisher","first-page":"23793","DOI":"10.1074\/jbc.M116.749283","article-title":"Very low density lipoprotein assembly is required for cAMP-responsive element-binding protein H processing and hepatic apolipoprotein A-IV expression.","volume":"291","author":"Cheng","year":"2016","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"G519","DOI":"10.1152\/ajpgi.00189.2007","article-title":"Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion.","volume":"293","author":"Black","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0337-x","article-title":"Increased ANGPTL3, 4 and ANGPTL8\/betatrophin expression levels in obesity and T2D.","volume":"15","author":"Abu-Farha","year":"2016","journal-title":"Lipids Health Dis."},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides.","volume":"377","author":"Graham","year":"2017","journal-title":"N Engl J Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1194\/jlr.RA120000888","article-title":"Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance.","volume":"61","author":"Adam","year":"2020","journal-title":"J Lipid Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5551\/jat.55244","article-title":"Endothelial lipase exerts its anti-atherogenic effect through increased catabolism of beta-VLDLs.","volume":"28","author":"Yan","year":"2021","journal-title":"J Atheroscler Thromb."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1161\/01.atv.11.5.1137","article-title":"Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.","volume":"11","author":"Hopkins","year":"1991","journal-title":"Arterioscler Thromb."},{"key":"B57","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.molmed.2020.07.005","article-title":"HDL and reverse remnant-cholesterol transport (RRT): relevance to cardiovascular disease.","volume":"26","author":"Kontush","year":"2020","journal-title":"Trends Mol Med."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121839","article-title":"The differential effects of HDL subpopulations on lipoprotein lipase (LPL)-mediated VLDL catabolism.","volume":"9","author":"Wieczorek","year":"2021","journal-title":"Biomedicines."},{"key":"B59","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.bbalip.2019.03.001","article-title":"Effects of triacylglycerol on the structural remodeling of human plasma very low- and low-density lipoproteins.","volume":"1864","author":"Jayaraman","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007079","article-title":"Common, low-frequency, and rare genetic variants associated with lipoprotein subclasses and triglyceride measures in Finnish men from the METSIM study.","volume":"13","author":"Davis","year":"2017","journal-title":"PLoS Genet."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145944","article-title":"HIF3A DNA methylation is associated with childhood obesity and ALT.","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One."},{"key":"B62","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2217\/epi.15.45","article-title":"HIF3A association with adiposity: the story begins before birth.","volume":"7","author":"Pan","year":"2015","journal-title":"Epigenomics."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.2337\/db21-0397","article-title":"Genetic studies of metabolomics change after a liquid meal illuminate novel pathways for glucose and lipid metabolism.","volume":"70","author":"Li-Gao","year":"2021","journal-title":"Diabetes."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13721-1","article-title":"Relationship between gut microbiota and circulating metabolites in population-based cohorts.","volume":"10","author":"Vojinovic","year":"2019","journal-title":"Nat Commun."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071461","article-title":"Subfractional spectrum of serum lipoproteins and gut microbiota composition in healthy individuals.","volume":"9","author":"Kashtanova","year":"2021","journal-title":"Microorganisms."},{"key":"B66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2337\/diab.27.12.1215","article-title":"Carbohydrate diet-induced changes in very low density lipoprotein composition and structure.","volume":"27","author":"Witztum","year":"1978","journal-title":"Diabetes."},{"key":"B67","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.4103\/jfmpc.jfmpc_1632_20","article-title":"Comparative study on fasting and postprandial lipid profile in type 2 diabetes mellitus.","volume":"10","author":"Chahal","year":"2021","journal-title":"J Family Med Prim Care."},{"key":"B68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2019.05.011","article-title":"A third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals.","volume":"286","author":"Balling","year":"2019","journal-title":"Atherosclerosis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5551\/jat.RV17004","article-title":"Triglyceride rich lipoprotein -LPL-VLDL receptor and Lp(a)-VLDL receptor pathways for macrophage foam cell formation.","volume":"24","author":"Takahashi","year":"2017","journal-title":"J Atheroscler Thromb."},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/189876","article-title":"Very-low-density lipoprotein: complex particles in cardiac energy metabolism.","volume":"2011","author":"Niu","year":"2011","journal-title":"J Lipids."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-020-01386-5","article-title":"The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome","volume":"19","author":"Lee","year":"2020","journal-title":"Lipids Health Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cca.2019.05.004","article-title":"The VLDL receptor plays a key role in the metabolism of postprandial remnant lipoproteins.","volume":"495","author":"Nakajima","year":"2019","journal-title":"Clin Chim Acta."},{"key":"B73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/09603123.2019.1680817","article-title":"Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model.","volume":"31","author":"Plazas Guerrero","year":"2021","journal-title":"Int J Environ Health Res."},{"key":"B74","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3945\/an.114.008144","article-title":"Health implications of high-fructose intake and current research.","volume":"6","author":"Dornas","year":"2015","journal-title":"Adv Nutr."},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-12-179","article-title":"Postprandial changes of lipoprotein profile: effect of abdominal obesity.","volume":"12","author":"Sabaka","year":"2013","journal-title":"Lipids Health Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41430-019-0459-0","article-title":"Effects of a diet naturally rich in polyphenols on lipid composition of postprandial lipoproteins in high cardiometabolic risk individuals: an ancillary analysis of a randomized controlled trial.","volume":"74","author":"Della Pepa","year":"2020","journal-title":"Eur J Clin Nutr."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072225","article-title":"Alternative foods in cardio-healthy dietary models that improve postprandial lipemia and insulinemia in obese people.","volume":"13","author":"Munoz-Perez","year":"2021","journal-title":"Nutrients."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014963","article-title":"Habitual fish consumption, n-3 fatty acids, and nuclear magnetic resonance lipoprotein subfractions in women.","volume":"9","author":"Amigo","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jacl.2016.09.005","article-title":"The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.","volume":"10","author":"Morton","year":"2016","journal-title":"J Clin Lipidol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1007\/s00394-021-02578-0","article-title":"Long-term fasting improves lipoprotein-associated atherogenic risk in humans.","volume":"60","author":"Grundler","year":"2021","journal-title":"Eur J Nutr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11745-014-3901-z","article-title":"Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes.","volume":"49","author":"Shakeri","year":"2014","journal-title":"Lipids."},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000528","article-title":"Towards more specific treatment for diabetic dyslipidemia.","volume":"29","author":"Rodriguez","year":"2018","journal-title":"Curr Opin Lipidol."},{"key":"B83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1573399810666140707092506","article-title":"Effect of GLP-1 based therapies on diabetic dyslipidemia.","volume":"10","author":"Patel","year":"2014","journal-title":"Curr Diabetes Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1194\/jlr.P029223","article-title":"Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome.","volume":"53","author":"Ooi","year":"2012","journal-title":"J Lipid Res."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0864-7","article-title":"The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMalpha) paradigm: conceptual framework and therapeutic potential : a consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.","volume":"18","author":"Fruchart","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.vph.2019.03.002","article-title":"Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.","volume":"116","author":"Hollstein","year":"2019","journal-title":"Vasc Pharmacol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease.","volume":"377","author":"Group","year":"2017","journal-title":"N Engl J Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11883-022-01013-x","article-title":"The role of non-statin lipid-lowering medications in youth with hypercholesterolemia.","volume":"24","author":"Butt","year":"2022","journal-title":"Curr Atheroscler Rep."},{"key":"B89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.31083\/j.rcm.2018.01.890","article-title":"Contribution of ApoCIII to diabetic dyslipidemia and treatment with volanesorsen.","volume":"19","author":"Zhang","year":"2018","journal-title":"Rev Cardiovasc Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2021.04.091","article-title":"Inhibition of angiopoietin-like protein 3 with evinacumab in subjects with high and severe hypertriglyceridemia.","volume":"78","author":"Ahmad","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.713048","article-title":"Associations between lipoprotein subfractions and area and density of abdominal muscle and intermuscular adipose tissue: the multi-ethnic study of atherosclerosis.","volume":"12","author":"Marron","year":"2021","journal-title":"Front Physiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2020.08.017","article-title":"Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease.","volume":"311","author":"Silbernagel","year":"2020","journal-title":"Atherosclerosis."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.993633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T07:21:53Z","timestamp":1664868113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.993633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":92,"alternative-id":["10.3389\/fcvm.2022.993633"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.993633","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,4]]},"article-number":"993633"}}